1. Home
  2. CTMX vs KLXE Comparison

CTMX vs KLXE Comparison

Compare CTMX & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • KLXE
  • Stock Information
  • Founded
  • CTMX 2008
  • KLXE 2018
  • Country
  • CTMX United States
  • KLXE United States
  • Employees
  • CTMX N/A
  • KLXE N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • CTMX Health Care
  • KLXE Energy
  • Exchange
  • CTMX Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • CTMX 85.3M
  • KLXE 89.2M
  • IPO Year
  • CTMX 2015
  • KLXE N/A
  • Fundamental
  • Price
  • CTMX $0.84
  • KLXE $4.57
  • Analyst Decision
  • CTMX Buy
  • KLXE Hold
  • Analyst Count
  • CTMX 6
  • KLXE 1
  • Target Price
  • CTMX $5.77
  • KLXE $4.50
  • AVG Volume (30 Days)
  • CTMX 943.6K
  • KLXE 182.8K
  • Earning Date
  • CTMX 03-10-2025
  • KLXE 03-05-2025
  • Dividend Yield
  • CTMX N/A
  • KLXE N/A
  • EPS Growth
  • CTMX N/A
  • KLXE N/A
  • EPS
  • CTMX 0.16
  • KLXE N/A
  • Revenue
  • CTMX $126,617,000.00
  • KLXE $738,000,000.00
  • Revenue This Year
  • CTMX $22.55
  • KLXE N/A
  • Revenue Next Year
  • CTMX N/A
  • KLXE $4.79
  • P/E Ratio
  • CTMX $5.39
  • KLXE N/A
  • Revenue Growth
  • CTMX 33.66
  • KLXE N/A
  • 52 Week Low
  • CTMX $0.79
  • KLXE $4.18
  • 52 Week High
  • CTMX $5.85
  • KLXE $9.80
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 45.15
  • KLXE 35.29
  • Support Level
  • CTMX $0.82
  • KLXE $5.04
  • Resistance Level
  • CTMX $0.98
  • KLXE $6.16
  • Average True Range (ATR)
  • CTMX 0.06
  • KLXE 0.51
  • MACD
  • CTMX 0.01
  • KLXE -0.19
  • Stochastic Oscillator
  • CTMX 33.58
  • KLXE 2.15

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: